相关实验视频

Updated: Jul 11, 2025

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Published on: July 21, 2023

斯特甲酸通过调节TGF-β1/NF-κB轴改善椎间盘退化

Ruping Sun¹, Jian Zhu², Kaiqiang Sun³

¹School of Health Science and Engineering, University of Shanghai for Science and Technology, No. 516 Jungong Road, Shanghai 200093, China.

International journal of medical sciences

|November 6, 2023

概括

兰酸 (SRR) 通过增强TGF-β1并通过NF-κB通路减少炎症来治疗椎间盘退化 (IVDD). 这项研究证实了SRRR.

科学领域:

生物医学科学生物医学科学
细胞生物学细胞生物学
分子生物学分子生物学

背景情况:

椎间盘退化 (IVDD) 导致慢性背痛和降低生活质量.
用于骨质疏松症的兰酸 (SRR) 显示出对胆红细胞的抗炎作用.
涉及炎症和氧化应激的IVDD的分子机制尚未完全理解.

研究的目的:

调查斯特伦兰酸盐 (SRR) 对椎间盘退化 (IVDD) 的治疗作用.
阐明SRR在治疗IVDD中的分子机制,重点关注TGF-β1和NF-κB通路.

主要方法:

在人类退化的圆盘组织中评估TGF-β1表达.
评估了SRR对人体细胞核脉细胞的作用,测量了增殖,炎症和氧化应激标志物.
利用分子对接,功能增益和丧失实验来确认SRR-TGF-β1相互作用和通路调节.
验证了SRR对IVDDin vivo的治疗效果.

主要成果:

在人类退化的椎间盘中观察到TGF-β1表达的减少.
SRR促进了核脉细胞的增殖,减少了炎症和氧化应激in vitro.
SRR增加了TGF-β1的表达,并抑制了NF-κB通路,SRR和TGF-β1.1之间的相互作用得到证实.
TGF-β1调制影响了NF-κB通路的激活,表明它在SRR机制中的作用.
在IVDD模型in vivo中,SRR证明了治疗疗效.

结论:

通过调节TGF-β1/NF-κB轴in vitro,SRR可以减轻人类细胞核中IL-1β诱导的细胞功能障碍.
在治疗椎间盘退化 (IVDD) 方面,SRR具有治疗潜力.
结果提供了对IVDD病原体和潜在的向治疗策略的见解.

关键词:

IVDDDD IVDD 是一个很好的方法.石甲基甲酸 (Strontium Ranelate) 是一种甲酸的化合物.在TGF-β1/NF-κB轴上有针对性的治疗.

更多相关视频

A Mouse Model of Lumbar Spine Instability

A Mouse Model of Lumbar Spine Instability

Published on: April 23, 2021

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.

Published on: February 14, 2021

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...